The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/15641
StudyName: Month 12 2nd cycle Trial Medication Multiple Sclerosis ALAIN01 NCT02419378
Date of export from the portal: 02.07.2020
Date of Upload / last change: 06.06.2016
License: Creative Commons BY 4.0

----

Description: 
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01)
https://clinicaltrials.gov/ct2/show/NCT02419378
Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany

Part: Month 12 2nd cycle Trial Medication
